| Brian Avery Shaw, PHARMD | |
|
890 Richmond Plz, Richmond, KY 40475-2564 | |
| (859) 624-1093 | |
| (859) 625-9386 |
| Full Name | Brian Avery Shaw |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 890 Richmond Plz, Richmond, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124653621 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 018619 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brian Avery Shaw, PHARMD 890 Richmond Plz, Richmond, KY 40475-2564 Ph: (859) 624-1093 | Brian Avery Shaw, PHARMD 890 Richmond Plz, Richmond, KY 40475-2564 Ph: (859) 624-1093 |
News Archive
Drug resistant bacteria are fast becoming one of the big worries of the 21 century. Now researchers at the University of Copenhagen have discovered a previously unknown weakness; an "Achilles heel", of bacteria. Their discovery, a crucial step in bacteria's energy metabolism, may be the first step in developing an entirely novel form of antibiotics
Scientists have identified a genetic variation in people with type 2 diabetes that affects how the body's muscle cells respond to the hormone insulin, in a new study published today in Nature Genetics.
High blood pressure is a well-known risk factor for heart disease. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have participated in an international study of 200,000 Europeans which has identified 16 new genetic variations that affect blood pressure. The discovery, presented in Nature, is an important step towards better diagnostics and treatment.
Seven Mount Sinai Health System hospitals have received top quality achievement awards from the American Heart Association for ensuring that patients with stroke, heart failure, and severe heart attacks receive the most appropriate and safest treatment for the best possible outcomes.
Sanofi and its subsidiary Genzyme announced today positive top-line results from CARE-MS I, the first of two randomized, Phase 3 clinical trials comparing the investigational drug alemtuzumab to the approved multiple sclerosis therapy Rebif in patients with relapsing-remitting multiple sclerosis.
› Verified 9 days ago
Michael Andrew Wood, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 114 Holly Hill Dr, Richmond, KY 40475 Phone: 859-248-1032 | |
Keeley Green Mathis, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 793 Eastern Byp Ste G01, Richmond, KY 40475 Phone: 859-626-0076 | |
Audrey Elaine Creech, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 415 Gibson Ln, Richmond, KY 40475 Phone: 859-353-6277 | |
Dr. Mikka Riley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2013 Lantern Ridge Dr, Richmond, KY 40475 Phone: 859-575-5000 | |
Mr. Stanley M Leach, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 238 E Main St, Richmond, KY 40475 Phone: 859-623-8900 Fax: 859-623-8901 | |
Dr. Regina Ann Dillon, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1115 Kim Kent Dr, Richmond, KY 40475 Phone: 859-623-5812 Fax: 859-624-4350 |